Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
An institute for the gifted with X in its name, presided over by a wise doctor, has launched two new projects. Somebody call Magneto!
What milestones will define the next era in the mRNA story?
A diverse range of malaria treatments will make all the difference in the prevention of resistance.
Is autologous cell therapy a realistic proposition for solid tumors?
Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.
The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?
How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.
Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.
Google’s DeepMind has opened its AlphaFold protein structure database to the world.
How can we maximize the potential and production of potentially life-saving therapies?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Pharma’s Green Progress and Pitfalls
A History of Missed Opportunity
The Candy Coder